Back

Baroreflex activation therapy for resistant hypertension: results from mid-term prospective ambulatory blood pressure registry

29 August 2020 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Devices in Hypertension Device Treatment and Intervention ESC Premium Access ESC Congress 2020

About the speaker

Photo
Mr Magnus Sindt

Heart Center - University Hospital Dresden, Dresden (Germany)

6 More presentations in this session

Presentation thumbnail
Electrophysiology-based assessment of the procedural success of radiofrequency renal denervation
Doctor S. Pekarskiy (Tomsk, RU)
Abstract Slides
Presentation thumbnail
Bilateral sphenopalatine ganglion block reduces blood pressure and blood pressure variability in never treated patients with essential hypertension
Doctor H. Triantafyllidi (Athens, GR)
Abstract Slides
Presentation thumbnail
Efficacy of radiofrequency RDN may be significantly improved if the procedure is guided by impedance drop during the treatment
Doctor S. Pekarskiy (Tomsk, RU)
Abstract Slides
Presentation thumbnail
Sympathetic renal denervation treatment in resistant hypertension: one-year follow-up
Doctor A. Moiseeva (Chisinau, MD)
Abstract Slides
Presentation thumbnail
A minimally-occlusive cuff method utilizing ultrasound vascular imaging for stress-free blood pressure measurement
Doctor K. UEMURA (Suita, JP)
Abstract Slides

Access the full session

Session thumbnail
Devices in Hypertension

The Event

Event poster

ESC Congress 2020

29 August - 1 September 2020
You may be interested in
thumbnail
Congress Presentation
Blood pressure should be lowered as low as possible - discussion
thumbnail
Congress Presentation
Renal denervation is one of the pillars of management of resistant hypertension: pro
thumbnail
Congress Presentation
Should we intervene early in patients with asymptomatic aortic stenosis?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources